Article info
PDFOriginal research
Immune gene expression profiles in high-grade urothelial carcinoma of the bladder: a NanoString study
- Correspondence to Dr Michelle R Downes, Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Canada; michelle.downes{at}sunnybrook.ca
Citation
Immune gene expression profiles in high-grade urothelial carcinoma of the bladder: a NanoString study
Publication history
- Received April 6, 2020
- Revised April 29, 2020
- Accepted May 1, 2020
- First published May 29, 2020.
Online issue publication
December 11, 2020
Article Versions
- Previous version (11 December 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.